Slight Change in FDA's Drug Safety Communication Plan

The Food and Drug Administration has issued a new guidance document, "Drug Safety Information--FDA's Communication to the Public," explaining how it communicates important drug safety information and the factors influencing when information is communicated. This guidance replaces an earlier version issued in May 2005, when FDA proposed a new communication channel -- the "Drug Watch" Web page -- to provide information on emerging drug safety issues.

The agency said it decided to eliminate the name "Drug Watch" to prevent potential confusion with FDA's existing "MedWatch" of safety alerts.

Jeffrey Shuren, assistant commissioner for Policy, signed the notice that appeared in yesterday's Federal Register.

Download Center

HTML - No Current Item Deck
  • EHS Management Software Buyer's Guide

    Download this buyer's guide to make more informed decisions as you're looking for an EHS management software system for your organization.

  • Steps to Conduct a JSA

    We've put together a comprehensive step-by-step guide to help you perform a job safety analysis (JSA), which includes a pre-built, JSA checklist and template, steps of a JSA, list of potential job hazards, and an overview of hazard control hierarchy.

  • Levels of a Risk Matrix

    Risk matrices come in many different shapes and sizes. Understanding the components of a risk matrix will allow you and your organization to manage risk effectively.

  • Free Safety Management Software Demo

    IndustrySafe Safety Management Software helps organizations to improve safety by providing a comprehensive toolset of software modules to help businesses identify trouble spots; reduce claims, lost days, OSHA fines; and more.

  • Industry Safe
Bulwark FR Quiz

OH&S Digital Edition

  • OHS Magazine Digital Edition - March 2021

    March 2021


      The Impact of COVID-19 on Drug Testing
      Preparing for Unpredictable Spring Weather
      Building a Comprehensive Floor Safety Strategy
      Gas Hazards and the COVID-19 Vaccine
    View This Issue